Gordian

Gordian, founded in 2018 and headquartered in San Francisco, is an in vivo drug discovery and development company with a mission to cure age-related diseases. The company, named for its approach to solving tough problems by changing the rules, has developed an innovative in vivo screening platform capable of testing thousands of gene therapies and predicting clinical outcomes with unprecedented accuracy and efficiency. The Gordian platform consists of three proprietary components that work together to enhance predictive power. Mosaic Screening is Gordian's pooled in vivo screening method, patient avatars are the animals that best represent humans, and Pythia is an analytical approach that combines Gordian screening data with existing human data, using machine learning to maximize predictive capability.